Company Profile - ViewRay Inc
Introduction
ViewRay Inc (ViewRay) is a medical device company that develops radiation therapy technology for the treatment of cancer. It provides MRIdian, a radiation therapy solution that enables treatment and real-time imaging of a patient’s anatomy simultaneously. The company offers MRIdian integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors although radiation is delivered. ViewRay’s technology MRIdian Linac uses the same split-magnet MRI system used in the MRIdian, which is designed to fit in standard radiotherapy vaults replacing X-ray guided linear accelerators. The company caters services to university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay is headquartered in Oakwood, Ohio, the US.
Company info
Country (HQ): | United States |
Sector: | Medical Equipment |
Market Cap (US$ m): | 114 |
Revenue (US$ m): | 102 (2022) |
Innovation ranking
Innovation score
Closest peers in the Medical Equipment sector
Innovation Ranking
Medtronic Plc
Ireland
Medical Equipment
Boston Scientific Corp
United States
Medical Equipment
ViewRay Inc
United States
Medical Equipment
Savara Inc
United States
Medical Equipment
Aethlon Medical Inc
United States
Medical Equipment
Are you ranked? Get the Innovation Ranking Report
-
Company Ranking Report
- If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
- Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
- Contextualised information on the company's standing in relation to peers
- Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
- Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
- Rosettes
- Certificate of Achievement
- Press release